Matches in SemOpenAlex for { <https://semopenalex.org/work/W3030091323> ?p ?o ?g. }
- W3030091323 abstract "ABSTRACT OBJECTIVE To examine if baseline soluble urokinase plasminogen activator receptor (suPAR) can predict whether patients with COVID-19 symptoms will need mechanical ventilation during a 14-day follow-up. Furthermore, to examine differences in demographics, clinical signs, and biomarkers in patients tested either positive or negative for SARS-CoV-2. DESIGN Prospective cohort study including patients presenting with symptoms of COVID-19. SETTING Copenhagen University Hospital Amager and Hvidovre, Hvidovre, Denmark. PARTICIPANTS 407 patients presenting with symptoms of COVID-19 were included from the Emergency Department (ED). Patients were included from March 19 to April 3 and follow-up data was collected until April 17, 2020. MAIN OUTCOME MEASURES Primary outcomes were respiratory failure in patients presenting with symptoms of COVID-19 and in those with a positive SARS-CoV-2 RT-PCR test, respectively. Furthermore, we analysed differences between patients testing positive and negative for SARS-CoV-2, and disease severity outcomes in SARS-CoV-2 positive patients according to baseline suPAR. BACKGROUND Patients admitted to ED with clinical signs or symptoms of COVID-19 infection need a safe and quick triage, in order to determine if an in-hospital stay is necessary or if the patient can safely be isolated in their own home with relevant precautions. suPAR is a biomarker previously shown to be associated with adverse outcomes in acute medical patients. We aimed to examine if suPAR at baseline presentation is predictive of respiratory failure in patients presenting with symptoms of COVID-19. Furthermore, we examined demographic, clinical, and biochemical differences between SARS-CoV-2-positive and negative patients. RESULTS Among the 407 symptomatic patients, the median (interquartile range) age was 64 years (47-77), 58% were women, and median suPAR was 4.2 ng/ml (2.7-6.4). suPAR level below 4.75 ng/ml at admission ruled out respiratory failure during follow-up with an area under the curve (95% CI) of 0.89 (0.85-0.94) and a negative predictive value of 99.5%. Of the 407 symptomatic patients, 117 (28.8%) had a positive RT-PCR test for SARS-CoV-2 and presented with significant differences in vital signs, cell counts, and biomarkers compared to SARS-CoV-2 negative patients. In SARS-CoV-2 positive patients eligible for mechanical ventilation (N=87), 26 (30%) developed respiratory failure. Best baseline predictors of respiratory failure were suPAR with an area under the curve (95% CI) of 0.88 (0.80-0.95), EWS 0.84 (0.75-0.93), lactate dehydrogenase 0.82 (0.71-0.93), and C-reactive protein 0.80 (0.70-0.89). CONCLUSION SARS-CoV-2 affects several patient parameters underpinning the severe impact of the infection. A low suPAR level (<4.75 ng/ml) at baseline is a useful biomarker for aiding clinical decisions including discharge of patients presenting with symptoms of COVID-19." @default.
- W3030091323 created "2020-06-05" @default.
- W3030091323 creator A5008206095 @default.
- W3030091323 creator A5012107602 @default.
- W3030091323 creator A5014963169 @default.
- W3030091323 creator A5016379546 @default.
- W3030091323 creator A5026416311 @default.
- W3030091323 creator A5054786321 @default.
- W3030091323 creator A5060715363 @default.
- W3030091323 creator A5064092427 @default.
- W3030091323 creator A5065895885 @default.
- W3030091323 creator A5071706658 @default.
- W3030091323 creator A5076068077 @default.
- W3030091323 creator A5089738102 @default.
- W3030091323 date "2020-06-02" @default.
- W3030091323 modified "2023-10-18" @default.
- W3030091323 title "Low levels of the prognostic biomarker suPAR are predictive of mild outcome in patients with symptoms of COVID-19 - a prospective cohort study" @default.
- W3030091323 cites W1569358024 @default.
- W3030091323 cites W2056619345 @default.
- W3030091323 cites W2093274439 @default.
- W3030091323 cites W2093815898 @default.
- W3030091323 cites W2112206125 @default.
- W3030091323 cites W2125145600 @default.
- W3030091323 cites W2508036347 @default.
- W3030091323 cites W2894812242 @default.
- W3030091323 cites W2900541949 @default.
- W3030091323 cites W2945871050 @default.
- W3030091323 cites W2969904308 @default.
- W3030091323 cites W2974837088 @default.
- W3030091323 cites W3008090866 @default.
- W3030091323 cites W3013449264 @default.
- W3030091323 cites W3014286413 @default.
- W3030091323 cites W3016127406 @default.
- W3030091323 cites W3021949095 @default.
- W3030091323 cites W3025289074 @default.
- W3030091323 cites W3028583791 @default.
- W3030091323 cites W3034768144 @default.
- W3030091323 doi "https://doi.org/10.1101/2020.05.27.20114678" @default.
- W3030091323 hasPublicationYear "2020" @default.
- W3030091323 type Work @default.
- W3030091323 sameAs 3030091323 @default.
- W3030091323 citedByCount "1" @default.
- W3030091323 countsByYear W30300913232020 @default.
- W3030091323 crossrefType "posted-content" @default.
- W3030091323 hasAuthorship W3030091323A5008206095 @default.
- W3030091323 hasAuthorship W3030091323A5012107602 @default.
- W3030091323 hasAuthorship W3030091323A5014963169 @default.
- W3030091323 hasAuthorship W3030091323A5016379546 @default.
- W3030091323 hasAuthorship W3030091323A5026416311 @default.
- W3030091323 hasAuthorship W3030091323A5054786321 @default.
- W3030091323 hasAuthorship W3030091323A5060715363 @default.
- W3030091323 hasAuthorship W3030091323A5064092427 @default.
- W3030091323 hasAuthorship W3030091323A5065895885 @default.
- W3030091323 hasAuthorship W3030091323A5071706658 @default.
- W3030091323 hasAuthorship W3030091323A5076068077 @default.
- W3030091323 hasAuthorship W3030091323A5089738102 @default.
- W3030091323 hasBestOaLocation W30300913231 @default.
- W3030091323 hasConcept C118552586 @default.
- W3030091323 hasConcept C126322002 @default.
- W3030091323 hasConcept C185592680 @default.
- W3030091323 hasConcept C188816634 @default.
- W3030091323 hasConcept C194828623 @default.
- W3030091323 hasConcept C201903717 @default.
- W3030091323 hasConcept C2776929539 @default.
- W3030091323 hasConcept C2777120189 @default.
- W3030091323 hasConcept C2779134260 @default.
- W3030091323 hasConcept C2779679481 @default.
- W3030091323 hasConcept C2780724011 @default.
- W3030091323 hasConcept C2781197716 @default.
- W3030091323 hasConcept C30036603 @default.
- W3030091323 hasConcept C3008058167 @default.
- W3030091323 hasConcept C524204448 @default.
- W3030091323 hasConcept C55493867 @default.
- W3030091323 hasConcept C56219504 @default.
- W3030091323 hasConcept C71924100 @default.
- W3030091323 hasConcept C72563966 @default.
- W3030091323 hasConceptScore W3030091323C118552586 @default.
- W3030091323 hasConceptScore W3030091323C126322002 @default.
- W3030091323 hasConceptScore W3030091323C185592680 @default.
- W3030091323 hasConceptScore W3030091323C188816634 @default.
- W3030091323 hasConceptScore W3030091323C194828623 @default.
- W3030091323 hasConceptScore W3030091323C201903717 @default.
- W3030091323 hasConceptScore W3030091323C2776929539 @default.
- W3030091323 hasConceptScore W3030091323C2777120189 @default.
- W3030091323 hasConceptScore W3030091323C2779134260 @default.
- W3030091323 hasConceptScore W3030091323C2779679481 @default.
- W3030091323 hasConceptScore W3030091323C2780724011 @default.
- W3030091323 hasConceptScore W3030091323C2781197716 @default.
- W3030091323 hasConceptScore W3030091323C30036603 @default.
- W3030091323 hasConceptScore W3030091323C3008058167 @default.
- W3030091323 hasConceptScore W3030091323C524204448 @default.
- W3030091323 hasConceptScore W3030091323C55493867 @default.
- W3030091323 hasConceptScore W3030091323C56219504 @default.
- W3030091323 hasConceptScore W3030091323C71924100 @default.
- W3030091323 hasConceptScore W3030091323C72563966 @default.
- W3030091323 hasLocation W30300913231 @default.
- W3030091323 hasOpenAccess W3030091323 @default.
- W3030091323 hasPrimaryLocation W30300913231 @default.
- W3030091323 hasRelatedWork W1982536824 @default.
- W3030091323 hasRelatedWork W1983536736 @default.